The expression levels of TOMM20 significantly decreased in PCa patients with lost AR and NE marker overexpression (Fig. 7E), which suggested the critical roles of TOMM20 in NEPC transition and drug sensitivity. The gene discussed is AR; the disease is posterior cortical atrophy.